ArticleBritish journal of haematology2026

The myeloid cell leukaemia-1 inhibitor MIK665 is a potent therapy in preclinical models of paediatric acute myeloid leukaemia.

Patrick Connerty et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.